yttrium radioisotopes has been researched along with Sarcoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ahrens, M; Bauer, S; Fendler, WP; Ferdinandus, J; Fragoso Costa, P; Hamacher, R; Herrmann, K; Kessler, L; Kostbade, K; Lippert, M; Lueckerath, K; Mavroeidi, IA; Pabst, KM; Rischpler, C; Schuler, M; Siveke, JT; Umutlu, L; Weber, M | 1 |
Haste, PM; Johnson, MS; Lewandowski, RJ; Miller, MD; Mpofu, P; Padia, SA; Salem, R; Sze, DY | 1 |
Ellis, S; Hahl, M; Martin, RC; McMasters, K; Scoggins, CR; Tatum, C; Whitney, R | 1 |
3 other study(ies) available for yttrium radioisotopes and Sarcoma
Article | Year |
---|---|
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities.
Topics: Humans; Male; Pancreatic Neoplasms; Prostatic Neoplasms; Quinolines; Sarcoma; Yttrium Radioisotopes | 2022 |
Response and Overall Survival for Yttrium-90 Radioembolization of Hepatic Sarcoma: A Multicenter Retrospective Study.
Topics: Aged; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Radiography, Interventional; Retrospective Studies; Sarcoma; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy.
Topics: Adult; Carcinoma, Adenosquamous; Cholangiocarcinoma; Colorectal Neoplasms; Combined Modality Therapy; Female; Gastrinoma; Gastrointestinal Neoplasms; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Microspheres; Middle Aged; Radiotherapy; Registries; Sarcoma; Treatment Outcome; Yttrium Radioisotopes | 2011 |